Laflamme leads team to unlock a cure for heart disease
Dr. Michael Laflamme, Professor in Laboratory Medicine and Pathobiology in the Temerty Faculty of Medicine, has received funding through the Government of Canada’s New Frontiers in Research Fund (NFRF) Transformation program.
The project, titled Enabling novel cardiac therapies with pluripotent stem cells, is highly collaborative. It was built out of core team of researchers at the McEwen, Toronto General Hospital Research Institute and the University of Toronto—in total, 22 leading laboratories will be involved across 10 research institutions in four countries (Canada, the United States, the United Kingdom and Israel).
Dr. Sara Vasconcelos, Associate Professor in LMP and Senior Scientist at the Toronto General Hospital Research Institute is a co-principal investigator on the project.
This initiative showcases the following pillars of the LMP strategic plan: Dynamic Collaboration (pillar 2), Impactful Research (Pillar 3) and Disruptive Innovation (Pillar 4)